Skip to main content
. 2001 Apr;39(4):1566–1570. doi: 10.1128/JCM.39.4.1566-1570.2001

FIG. 1.

FIG. 1

Agarose gel electrophoresis analysis of SAG2 PCR amplification products and restriction digests from T. gondii-infected clinical samples. (A) Sau3AI restriction analysis of the 5′ amplification products and (B) HhaI restriction analysis of the 3′ amplification products. Lane I, DNA from strain RH (type I); lane II, DNA from strain Beverly (type II); lane III, DNA from strain C56 (type III). Lanes 1 to 8 contain strains from clinical samples as follows: lane 1, CSF from patient 1 IHIV+ (type I); lane 2, CSF from patient 5 IHIV+ (type II); lane 3, blood from patient 7 Cnewborn (type II); lane 4, blood from patient 5 Cnewborn (type I); lane 5, CSF from patient 14 IHIV+ (type III); lane 6, vitreous humor from patient 12 IHIV+ (type II); lane 7, blood from patient 8 Cnewborn (type III); lane 8, brain (from biopsy) from patient 8 IHIV+ (type II). Lane M, molecular weight markers.